Tretinoin gel microsphere pump 0.04% plus 5% benzoyl peroxide wash for treatment of acne vulgaris: Morning/morning regimen is as effective and safe as morning/evening regimen

Journal of Drugs in Dermatology

Volumn 9, Issue 7, 2010, Pages 805-813

  Pariser, David ^a   Bucko, Alicia ^b   Fried, Richard ^c   Jarratt, Michael T ^d   Kempers, Steven ^e   Kircik, Leon ^f   Lucky, Anne W ^g   Rafal, Elyse ^h   Rendon, Marta ⁱ   Weiss, Jonathan ^j   Wilson, David C ^k   Rossi, Ana Beatris ^l   Ramaswamy, Ratna ^l   Nighland, Marge ^l  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b Academic Dermatology Associates   (United States)

^c Yardley Dermatology Associates   (United States)

^d DermResearch Inc   (United States)

^e Minnesota Clinical Study Center   (United States)

^f Physicians Skin Care PLLC   (United States)

^g Dermatology Research Associates   (United States)

^h DermResearchCenter of New York Inc   (United States)

ⁱ Skin Care Research Inc   (United States)

^j Gwinnett Clinical Research Center   (United States)

^k Education and Research Foundation   (United States)

^l JOHNSON AND JOHNSON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYL PEROXIDE; MICROSPHERE; RETINOIC ACID; TRETINOIN GEL MICROSPHERE; UNCLASSIFIED DRUG;

ACNE VULGARIS; ARTICLE; BACTERIAL SINUSITIS; BACTERIAL SKIN DISEASE; BEDTIME DOSAGE; CELLULITIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG TOLERABILITY; DRY SKIN; ERYTHEMA; FEMALE; GASTROENTERITIS; HUMAN; INFECTIOUS MONONUCLEOSIS; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MULTICENTER STUDY; PATIENT COMPLIANCE; PHASE 4 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SINGLE BLIND PROCEDURE; SKIN BURNING SENSATION; SKIN EXFOLIATION; TREATMENT DURATION; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; VIRUS MYOCARDITIS; ADOLESCENT; ADULT; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG COMBINATION; GEL;

ACNE VULGARIS; ADOLESCENT; ADULT; BENZOYL PEROXIDE; CHILD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GELS; HUMANS; MALE; TRETINOIN;

EID: 77955914290     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Fakhouri T, Yentzer BA, Feldman SR. Advancement in benzoyl peroxide- based acne treatment: Methods to increase both efficacy and tolerability. J Drugs Dermatol. 2009;8:657-661.
2. Oberemok SS, Shalita AR. Acne vulgaris, I: Pathogenesis and diagnosis. Cutis. 2002;70:101-105. (Pubitemid 41757461)
3. Kim J. Review of the innate immune response in acne vulgaris: Activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology. 2005;211:193-198. (Pubitemid 41415858)
4. Thiboutot D, Gollnick H, Bettoli V, et al., for the Global Alliance to Improve Outcomes in Acne. New insights into the management of acne: An update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. 2009;60(5 suppl):S1-S50.
5. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: A report from Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(1 suppl):S1-S37. (Pubitemid 36791495)
6. Alexis AF. Clinical considerations on the use of concomitant therapy in the treatment of acne. J Dermatolog Treat. 2008;19:199-209.
7. Jorizzo J, Grossman R, Nighland M. Tretinoin microsphere gel in younger acne patients. J Drugs Dermatol. 2008;7(8 suppl):S9-S13.
8. Berger R, Rizer R, Barba A, et al. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: A 12-week, multicenter, randomized, double-blind, parallel- group, phase IV trial. Clin Ther. 2007;29:1086-1097. (Pubitemid 47198892)
9. Shalita AR, Rafal ES, Anderson DN, et al. Compared efficacy and safety of tretinoin 0.1% microsphere gel alone and in combination with benzoyl peroxide 6% cleanser for the treatment of acne vulgaris. Cutis. 2003;72:167-172. (Pubitemid 37229749)
10. Leyden JJ, Shalita A, Thiboutot D, et al. Topical retinoids in inflammatory acne: A retrospective, investigator-blinded, vehicle-controlled, photographic assessment. Clin Ther. 2005;27:216-224. (Pubitemid 40462015)
11. Embil K, Nacht S. The Microsponge Delivery System (MDS): A topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives. J Microencapsul. 1996;13:575-588. (Pubitemid 26283810)
12. Nyirady J, Bennett ML. Advancement of tretinoin through the microsphere technology. Cosmetic Dermatology. 2001;14:22-24.
13. Webster G. Mechanism-based treatment of acne vulgaris: the value of combination therapy. J Drugs Dermatol. 2005;4:281-288.
14. Tanghetti EA, Popp KF. A current review of topical benzoyl peroxide: new perspectives on formulation and utilization. Dermatol Clin. 2009;27:17-24.
15. Leyden JJ, Wortzman M, Baldwin EK. Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%. Cutis. 2008;82:417-421.
16. Ghali F, Kang S, Leyden J, et al. Changing the face of acne therapy. Cutis. 2009;83(2 suppl):4-15.
17. Kircik LH. Comparative efficacy and safety results of two topical combination acne regimens. J Drugs Dermatol. 2009;8:624-630.
18. Krakowski AC, Stendardo S, Eichenfield LF. Practical considerations in acne treatment and the clinical impact of topical combination therapy. Pediatr Dermatol. 2008;1(25 suppl):1-14. (Pubitemid 351725096)
19. Nyirady J, Lucas C, Yusuf M, et al. The stability of tretinoin in tretinoin gel microsphere 0.1%. Cutis. 2002;70:295-298. (Pubitemid 41750803)
20. Nighland M, Yusuf M, Wisniewski S, et al. The effect of simulated solar radiation on tretinoin in tretinoin gel microsphere, 0.1%. Cutis. 2006;77:313-316. (Pubitemid 43845324)
21. Fleming TR. Current issues in non-inferiority trials. Stat Med. 2008;27:317-332. (Pubitemid 351227869)